Ionis Pharma (IONS) Tops Q4 EPS by 33c

Ionis Pharma (NASDAQ: IONS) reported Q4 EPS of $0.21, $0.33 better than the analyst estimate of ($0.12). Revenue for the quarter came in at $160.3 million versus the consensus estimate of $97.47 million.

For earnings history and earnings-related data on Ionis Pharma (IONS) click here.

You May Also Be Interested In

• FedEx falls 4% as CY2026 profit forecast misses expectations despite Q4 beat
• RBC initiates GE HealthCare as it sees AI-led innovation cycle driving growth
• BofA lists top 5 themes driving next $1tn in incremental semi sales